- Cash
Volume Analysis
SPOT Pivot Levels
| Type | Classic | Fibonacci |
|---|---|---|
| R1 | - | - |
| R2 | - | - |
| R3 | - | - |
| PP | - | - |
| S1 | - | - |
| S2 | - | - |
| S3 | - | - |
Ratios
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| ROCE | - | 4.82 | - | 5.54 | - |
| ROE | - | 2.14 | - | 1.55 | - |
| EPS | 0.84 | 0.46 | 0.16 | 0.19 | 0.11 |
Peer Comparison
| Scrip Name | Price | Daily change | M Cap | PE Ratio | 1 Year Return |
|---|---|---|---|---|---|
| No data available | |||||
Corporate Action
- Announcements
- Board Meetings
- Dividends
- Bonus
- Splits
- Rights
- AGM/EGM
- Credit Rating
About Concord Drugs Ltd
Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets.
The principal activity of the Company is to manufacture licensed drugs based o...
ISIN :INE858L01010
Registered Office
Survey No 249 Brahmanapally V,Hayathnagar M
Contact number
+ 91-40-24036379
Registrars
Aarthi Consultants Pvt Ltd
1-2-285 Domalguda Hyderabad - 500 029
1-2-285 Domalguda Hyderabad - 500 029
Contact number
+ 91-040-27638111/4445
Management
S Nagi Reddy (Chairman)
Open IPO’s
Price Range
₹120 - ₹127
Min. Quantity
2,000 Shares
Min. investment
₹2,54,000
Closes on
September 8, 2026
FAQs
The share price of Concord Drugs Ltd on the BSE is - as on -